SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending as part of a broader surge in quantum computing stocks, with community members actively discussing its potential for significant gains. Optimism stems from upcoming events, potential government contracts, and the company's technology for optimization, though some express concerns about the current valuation. Overall, there's a sense of FOMO (fear of missing out) driving interest in QBTS.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending following news of a memorandum of understanding with the U.S. Department of Energy, sparking excitement about quantum technologies in space. Community discussions revolve around the company's growth potential, comparisons to other tech stocks, and debate over valuation amid a short squeeze. Some are closely watching for a potential Trump-related announcement that could further boost the stock.

MicroAlgo, Inc. operates as a holding company, which engages in the development and application of bespoke central processing algorithms. Its services include algorithm optimization, accelerating computing power without the need for hardware upgrades, lightweight data processing, and data intelligence. The company was founded May 14, 2018 and is headquartered in New York, NY.

MicroAlgo Inc

MicroAlgo ($MLGO) is trending as traders discuss its potential for a short squeeze and its connection to WIMI. The stock's small float and updates around AI and blockchain are attracting attention, with some highlighting its history of volatile runs and comparing it to other high-flying stocks. Community members are also weighing in on the company's fundamentals and potential catalysts, like a move into crypto.

BGM Group Ltd. is a pharmaceutical and chemical company. It focuses on the research, development, manufacture, marketing, and sale of oxytetracycline products, licorice products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. The Licorice products include Gan Di Xin, Qilian Shan Licorice Extract, and Qilian Shan Licorice Liquid Extract. The Oxytetracycline products consists of Qilian Shan Oxytetracycline Tablets and Qilian Shan Oxytetracycline Active Pharmaceutical Ingredients (API). The TCMD product includes Ahan antibacterial paste, which is made from a mixture of traditional Chinese herbal ingredients. The heparin product includes Heparin Sodium Preparations. The Sausage Casings products include Zhu Xiaochang Sausage Casings, which are all-natural food products used for culinary purposes. The Fertilizer products is composed of Xiongguan Organic Fertilizer and Xiongguan Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.

BGM Group Ltd. - Ordinary Shares - Class A

BGM Group Ltd

BGM Group (BGM) is trending due to strong community interest in its AI pivot and recent earnings report, which highlighted revenue growth driven by AI and insurance businesses. Community members are closely watching key technical levels and institutional accumulation, speculating on potential catalysts for a breakout. The stock's unique combination of AI, fintech, and robotics is generating discussion about its long-term potential and comparison to other high-growth AI companies.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as the market digests recent rate cut news and anticipates potential impacts on inflation and economic growth. Community discussions revolve around market direction, with some highlighting bullish signals and others warning of a potential downturn. Rotation into value stocks and the influence of AI on the job market are also being actively discussed.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending amid mixed sentiment, with some traders pointing to technical analysis suggesting a pullback before a potential move higher, while others cite regulatory scrutiny and cost pressures as reasons for concern. Discussions revolve around potential price targets, options activity, and speculation about upcoming news or a meeting with the Trump administration. Some investors view UNH as undervalued, while others anticipate a further decline.

89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.

89bio Inc

89bio is trending following news of its acquisition by Roche, driving excitement and speculation about the future of the MASH space. The community is discussing the potential $20.50 per share value for shareholders and what this acquisition means for other companies in the sector, with some highlighting $ETNB's long downtrend before the buyout news. Community members are now looking for the next potential buyout target in the biotech space.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors react to news of partnerships and positive milestones, with some highlighting its potential in the quantum computing sector. The community is actively discussing the company's progress toward commercial viability and comparing it to sector peers. Despite discussions of profitability, many see RGTI as a long-term play with significant potential.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares

SOXS is trending as traders discuss its continued decline despite some semi stocks showing weakness, with community members expressing frustration over the ETF's tracking and potential manipulation. Some are hoping for a market correction or hawkish comments from the Fed to provide a catalyst for a reversal. Others are speculating about potential impacts from upcoming earnings and economic data.

Bullish engages in the management of a digital asset platform. It also offers market infrastructure and information services. The company was founded by Brendan Francis Blumer in 2020 and is headquartered in George Town, Cayman Islands.

Bullish

Bullish is trending following the announcement of securing a BitLicense from the New York State Department of Financial Services, seen by the community as a significant step for U.S. expansion. Community members are also discussing the firm's earnings report, which beat analyst estimates. Some traders are expressing optimism for potential upgrades and a continued rally, while others remain cautious, citing past performance and broader market conditions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Retail chatter around IM Cannabis Corp. surged Wednesday after the company announced its request for voluntary delisting from the Canadian Securities Exchange (CSE).Shares of IM Cannabis surged 45.7% to close at $2.71 on Wednesday, before slipping slightly by 0.37% to $2.7 in after-hours trading.IM Cannabis said that its NASDAQ listing will remain unaffected by the CSE delisting, allowing shareholders to continue trading shares without disruptions.The company identified the high costs and administrative demands associated with regulatory approvals for dual listings as primary factors in its decision-making process.&nbsp;IM Cannabis said that focusing all its trading activity on NASDAQ will improve liquidity and create long-term shareholder value through a concentrated share market.If CSE approves the change, trading activity on the Canadian exchange will terminate post-business close on June 2.In the third quarter (Q3), IM Cannabis posted a 66% increase in revenue from the previous year in Germany, reaching CA$5.8 million ($4.1 million).&nbsp;The company recorded a 12% increase in total revenue, reaching CA$13.9 million ($10 million), compared to the previous year.&nbsp;It saved costs by reducing selling and marketing costs by 41% and cutting total operating expenses by 16%.&nbsp;Year-over-year core losses decreased by 68%, while the net loss declined by almost 50% to CA$1 million ($722,303).On Stocktwits, retail sentiment was ‘extremely bullish’ amid ‘extremely high’ message volume.One user anticipated the stock to reach $5 soon, with one user suggesting a move above $5 could happen as early as tomorrow.<stembedurl>https://stocktwits.com/hanoverfisteeDAD/message/616117911</stembedurl><stembedurl>https://stocktwits.com/hanoverfisteeDAD/message/616100340</stembedurl>The stock has risen nearly 19% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail Buzz Surges As IM Cannabis Plans Canadian Exchange Delisting; Investors Hope For Near 100% Rally

The company revealed plans to delist from the Canadian Exchange, citing cost savings and improved liquidity on NASDAQ. 

Equity

IM Cannabis Announces Change of Auditors

IM Cannabis Announces Change of Auditors IM Cannabis Announces Change of Auditors PR Newswire TORONTO and GLIL YAM, Israel, Jan. 17, 2025 TORONTO and GLIL YAM, Israel, Jan. 17, 2025 /PRNewswire...

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3

International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported...

IM Cannabis Reports Third Quarter Financial Results

IM Cannabis Reports Third Quarter Financial Results IM Cannabis Reports Third Quarter Financial Results PR Newswire TORONTO and GLIL YAM, Israel, Nov. 14, 2024 IMC pairs a +12% increase in revenue...

IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know

Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000...

IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management

IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management PR Newswire TORONTO and...

IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2

IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2 IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2 PR Newswire...

IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors PR Newswire TORONTO and GLIL YAM, Israel, Sept. 11...

IM Cannabis Corp: Strategic Refocus Amidst Challenges

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a player in the cannabis market, is refocusing its efforts by exiting the Ca...

IM Cannabis Reports Second Quarter Financial Results

IM Cannabis Reports Second Quarter Financial Results IM Cannabis Reports Second Quarter Financial Results PR Newswire TORONTO and GLIL YAM, Israel, Aug. 14, 2024 IMC Germany delivers +200% in sales...

IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under the IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.

IM Cannabis Corp

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$1.90
Prev Close	$1.96
Open	$1.97
Dividend Yield	0.00%
50-Day Moving Average	$2.59
Beta	0.18
Avg. Volume	42,797.71
PE Ratio	-3.61

52-Week High	$7.12
52-Week Low	$1.29
Market Capitalization	$6.05M
EPS (Annual)	-$3.29
Price to Book	3.07
Revenue Per Employee	$717,087.13
Enterprise Value/EBITDA	N/A

IMCC
IM Cannabis Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMCC News

IMCC IM Cannabis Corp